Product image of Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc) supplied by GNH India

Multibic

Active Ingredient:
Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc
Origin:
EU

Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc)

Sodium Hydrogen Carbonate, the active ingredient in Multibic, is an electrolyte solution presented as a sterile solution for intravenous infusion for haemodialysis use. It provides bicarbonate buffering and essential electrolytes to correct acid‑base and electrolyte disturbances during renal replacement therapy. The formulation also contains magnesium chloride, potassium chloride, sodium chloride and calcium, delivering a balanced composition that supports physiological ion levels throughout the treatment session.

GNH India supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Fresenius Medical Care Deutschland Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Multibic is used in renal replacement therapy to manage electrolyte and acid‑base balance during haemodialysis.

  • Haemodialysis: Maintains electrolyte concentrations and provides bicarbonate buffering during the procedure.
  • Metabolic acidosis: Corrects low blood pH by supplying bicarbonate during dialysis.
  • Renal replacement therapy: Supports overall electrolyte homeostasis throughout treatment.

How It Works

  • Multibic delivers sodium hydrogen carbonate, which dissociates to bicarbonate ions that buffer excess hydrogen ions, raising blood pH. Simultaneously, the solution supplies sodium, potassium, magnesium and chloride ions, replenishing those lost in the dialysis circuit and preserving osmotic balance. The combined effect restores normal acid‑base status and electrolyte concentrations, facilitating safe and effective haemodialysis.

Side Effects

Multibic may be associated with several adverse reactions, which are categorized by frequency.

Common Side Effects

  • Mild nausea or gastrointestinal discomfort.
  • Transient hypotension during infusion.
  • Local irritation at the infusion site.
  • Mild headache.
  • Small shifts in serum electrolytes, such as mild hyperkalemia.

Serious or Rare Side Effects

  • Severe hyperkalemia leading to cardiac arrhythmia.
  • Significant hypertension.
  • Anaphylactic or severe allergic reaction.
  • Metabolic alkalosis.
  • Life‑threatening cardiac arrhythmias.

Precautions & Warnings

When using Multibic, clinicians should observe the following precautions to minimise risk.

  • Patient assessment: Evaluate baseline electrolyte levels and acid‑base status before infusion.
  • Infusion rate: Adjust rate according to dialysis prescription and patient tolerance.
  • Monitoring: Continuously monitor blood pressure, heart rhythm and serum electrolytes during treatment.
  • Contraindications: Avoid in patients with severe hyperkalemia or uncontrolled hypertension.
  • Compatibility: Use only with compatible dialysis machines and tubing as specified by the manufacturer.
  • Store at ambient temperature: Keep the solution below 25 °C, protected from light and moisture, in the original sealed container.

Avoid Interactions

Multibic can interact with certain medications and solutions; awareness of these interactions helps ensure safe use.

Major Interactions (Avoid)

  • Concurrent use of high‑dose potassium supplements may cause dangerous hyperkalemia.
  • Co‑administration with other bicarbonate‑containing solutions can lead to metabolic alkalosis.
  • Use with calcium‑channel blockers that affect vascular tone may exacerbate hypotension.

Moderate Interactions (Monitor Closely)

  • Loop diuretics may increase electrolyte losses, requiring closer monitoring.
  • ACE inhibitors or ARBs can alter potassium balance, necessitating serum checks.
  • Anticoagulants used during dialysis (heparin) may increase bleeding risk if volume status changes rapidly.

Frequently Asked Questions

Multibic is an electrolyte solution used as an adjunct in renal replacement therapy, primarily to correct acid‑base disturbances and maintain electrolyte balance during haemodialysis sessions.

Sodium Hydrogen Carbonate dissociates into bicarbonate ions that neutralise excess hydrogen ions, raising blood pH. The solution also supplies sodium, potassium, magnesium and chloride, replenishing ions lost during dialysis and supporting osmotic equilibrium.

The prescribed volume and infusion rate of Multibic are determined by the treating physician based on the individual’s dialysis prescription, electrolyte profile and clinical condition. No fixed dose is provided in the product information.

Safety data for Multibic in pregnant or lactating women are limited. It should only be used if the potential benefit justifies any possible risk to the mother or infant, and under close medical supervision.

To order Multibic, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Multibic contains a balanced mix of bicarbonate and key electrolytes, similar to standard bicarbonate‑based dialysis solutions. Its specific composition, including magnesium and calcium, may offer additional electrolyte stability compared with some generic formulations, but clinical choice depends on patient needs and institutional protocols.

Multibic should be stored at ambient temperature, preferably below 25 °C, in its original sealed container. Protect the solution from direct sunlight, moisture and extreme temperature fluctuations to maintain sterility and potency.

Multibic is supplied as a sterile solution for intravenous infusion and is introduced into the dialysis circuit according to the prescribed dialysis protocol. It is administered under the supervision of trained healthcare professionals during the haemodialysis session.

Serious risks include severe hyperkalemia, metabolic alkalosis, significant hypertension or hypotension, and rare anaphylactic reactions. Continuous monitoring of blood pressure, cardiac rhythm and serum electrolytes is essential to detect and manage these events promptly.

Multibic should be avoided in patients with known severe hyperkalemia, uncontrolled hypertension, or a documented hypersensitivity to any of its components. Clinicians should also exercise caution in patients with unstable cardiovascular status or severe electrolyte imbalances.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.